Skip to content

BMT Data Book Including Cellular Therapy

ISBN-10: 1107617553

ISBN-13: 9781107617551

Edition: 3rd 2013 (Revised)

Authors: Reinhold Munker, Gerhard C. Hildebrandt, Hillard M. Lazarus, Kerry Atkinson

Shipping box This item qualifies for FREE shipping.
Blue ribbon 30 day, 100% satisfaction guarantee!
Buy eBooks
what's this?
Rush Rewards U
Members Receive:
Carrot Coin icon
XP icon
You have reached 400 XP and carrot coins. That is the daily max!

Description:

This is an essential guide to the data, basic science, outcome studies and decision-making processes involved in blood and marrow stem cell transplantation. Organized according to disease types and procedures, it contains more than 100 tables, figures and algorithms that reflect up-to-date research and give guidance on the choices between different types of chemotherapy, autologous vs. allogeneic transplantation, peripheral blood vs. bone marrow stem cells, and standard vs. experimental treatments. This new edition summarizes the research of the last four years and gives mature data for all established indications, such as acute myeloid leukemia, myelodysplastic syndrome and Hodgkin and non-Hodgkin lymphomas. New chapters discuss global trends in stem cell transplantation, cellular therapies including donor lymphocytes, and pediatric neurologic and metabolic disorders. With an expanded complications section, links to electronic databases and discussion of new drugs and alternative stem cell sources, this text belongs in every transplant unit.
Customers also bought

Book details

Edition: 3rd
Copyright year: 2013
Publisher: Cambridge University Press
Publication date: 2/21/2013
Binding: Paperback
Pages: 555
Size: 6.25" wide x 9.25" long x 1.00" tall
Weight: 2.046
Language: English

Gerhard C. Hildebrandt, MD is Associate Professor of Medicine, Department of Medicine, Division of Hematology-Oncology, Louisiana State University, Shreveport, LA, USA.

Preface
Basic Science
Hematopoietic cell transplantation: past, present and future
Basic science
Hematologic Malignancies
Therapeutic decision making in BMT/SCT for acute myeloid leukemia
Therapeutic decision making in BMT/SCT for acute lymphoblastic leukemia
Therapeutic decision making in BMT/SCT for chronic myeloid leukemia and other myeloproliferative syndromes
Therapeutic decision making in BMT/SCT for chronic lymphatic leukemia
Therapeutic decision making in BMT/SCT for myelodysplasia
Hematopoietic cell transplantation for non-Hodgkin lymphoma
Therapeutic decision making in BMT/SCT for Hodgkin lymphoma
Therapeutic decision making in hematopoietic stem cell transplantation for multiple myeloma
Therapeutic decision making in SCT for amyloidosis
Solid Tumors
Therapeutic decision making in BMT/SCT for nonseminomatous germ cell tumor of testis (NSGCT)
Therapeutic decision making in BMT/SCT for renal cell cancer
Therapeutic decision making in BMT/SCT for soft tissue sarcomas
Nonmalignant Disorders
Therapeutic decision making in BMT/SCT for severe aplastic anemia
Therapeutic decision making in BMT/SCT for congenital immunodeficiencies
Therapeutic decision making in BMT/SCT for hemoglobinopathies
Hematopoietic stem cell transplantation for inborn errors of metabolism and neurodegenerative disorders
Therapeutic decision making in BMT/SCT for autoimmune disorders
Cellular therapy
Practical Aspects and Procedures
Practical aspects and procedures, including conditioning protocols and haploidentical transplantation
Umbilical cord blood as alternative allogeneic graft source: clinical banking and transplant outcomes
Complications
Pathobiology of graft-versus-host disease
Diagnosis and treatment of graft-versus-host-disease
Management and prophylaxis of infections after BMT/SCT
Organ-related and miscellaneous complications
The BMT/SCT Pharmacopoeia
The BMT/SCT pharmacopoeia
HLA-Testing and Laboratory Medicine
HLA-testing and laboratory medicine
Appendix: guide to the internet and literature databases relevant for bone marrow and stem cell transplantation
Index